InsiderTrades

Form 4 for RXST RxSight, Inc.

Accepted 2024-02-12 00:00:00 ET · period of report 2024-02-09 · accession 0000950170-24-014006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2024-02-12 2024-02-09 RXST Goldshleger Ilya COO M - OptEx $20.90 +10.4K 36.8K +39% +$216.6K
DMT 2024-02-12 2024-02-09 RXST Goldshleger Ilya COO S - Sale+OE $50.74 -10.4K 31.5K -25% -$525.9K
DMT 2024-02-12 2024-02-09 RXST Goldshleger Ilya COO M - OptEx $0.00 -10.4K 3,995 -72% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-09 M A 5,365 $18.90 31,840 D — —
2 Common Common Stock 2024-02-09 S D 5,000 $51.00 26,475 D — —
3 Common Common Stock 2024-02-09 S D 5,365 $50.50 31,475 D — — (F2) Represents the weighted average share price of an aggregate total of 5,365 shares sold in the price range of $50.50 to $50.54 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
4 Common Common Stock 2024-02-09 M A 5,000 $23.04 36,840 D — —
5 Derivative Stock Option (right to buy) 2024-02-09 M D 5,000 $0.00 25,000 D $23.04 · 2021-04-18 to 2029-04-17 5,000 Common Stock
6 Derivative Stock Option (right to buy) 2024-02-09 M D 5,365 $0.00 3,995 D $18.90 · 2022-07-26 to 2028-07-25 5,365 Common Stock